These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8999706)

  • 1. [Long-term results of organ preserving therapy in ovarian carcinoma].
    Meier W; Korell M; Burges A; Hepp H
    Zentralbl Gynakol; 1996; 118(10):545-8. PubMed ID: 8999706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
    Zivanovic O; Braun M; Park TW; Kuhn W
    Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
    Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
    Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
    Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.